| Literature DB >> 19847666 |
Dottie R Brundige1, Elizabeth A Maga, Kirk C Klasing, James D Murray.
Abstract
Nutrition, bacterial composition of the gastrointestinal tract, and general health status can all influence the metabolic profile of an organism. We previously demonstrated that feeding pasteurized transgenic goats' milk expressing human lysozyme (hLZ) can positively impact intestinal morphology and modulate intestinal microbiota composition in young pigs. The objective of this study was to further examine the effect of consuming hLZ-containing milk on young pigs by profiling serum metabolites. Pigs were placed into two groups and fed a diet of solid food and either control (non-transgenic) goats' milk or milk from hLZ-transgenic goats for 6 weeks. Serum samples were collected at the end of the feeding period and global metabolite profiling was performed. For a total of 225 metabolites (160 known, 65 unknown) semi-quantitative data was obtained. Levels of 18 known and 4 unknown metabolites differed significantly between the two groups with the direction of change in 13 of the 18 known metabolites being almost entirely congruent with improved health status, particularly in terms of the gastrointestinal tract health and immune response, with the effects of the other five being neutral or unknown. These results further support our hypothesis that consumption of hLZ-containing milk is beneficial to health.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19847666 PMCID: PMC2902735 DOI: 10.1007/s11248-009-9334-4
Source DB: PubMed Journal: Transgenic Res ISSN: 0962-8819 Impact factor: 2.788
Significant known metabolite changes observed between hLZ-fed and control-fed pigs
| Metabolite | hLZ mean ± SD | Control mean ± SD | hLZ median | Control median | Median ratio (hLZ/control) | Median ratio |
|---|---|---|---|---|---|---|
| Amino acids | ||||||
| Methionine | 0.991 ± 0.102 | 0.605 ± 0.083 | 0.885 | 0.543 | 1.464 | 0.003 |
| Threonine | 0.942 ± 0.089 | 0.730 ± 0.062 | 0.877 | 0.712 | 1.201 | 0.039 |
| Amino acid derivatives | ||||||
| 3-Hydroxyindolea | 0.336 ± 0.097 | 0.625 ± 0.108 | 0.367 | 0.618 | 0.587 | 0.001 |
| Urea | 0.689 ± 0.062 | 0.999 ± 0.093 | 0.685 | 0.919 | 0.686 | 0.008 |
| | 1.078 ± 0.065 | 0.826 ± 0.066 | 1.112 | 0.829 | 1.345 | 0.012 |
| Citrulline | 1.359 ± 0.106 | 0.962 ± 0.132 | 1.386 | 0.950 | 1.440 | 0.049 |
| Carbohydrates and related | ||||||
| 1,5-Anhydrosorbitol | 1.249 ± 0.051 | 0.833 ± 0.083 | 1.287 | 0.820 | 1.545 | 0.002 |
| Scyllo-inositol | 0.820 ± 0.102 | 0.602 ± 0.082 | 0.801 | 0.575 | 1.330 | 0.035 |
| Myo-inositol | 0.675 ± 0.124 | 0.467 ± 0.103 | 0.650 | 0.471 | 1.393 | 0.041 |
| Energy metabolism and related | ||||||
| Alpha-ketoglutarate | 1.249 ± 0.132 | 0.795 ± 0.116 | 1.187 | 0.799 | 1.492 | 0.024 |
| Fatty acids | ||||||
| Arachidonic acid | 1.116 ± 0.038 | 0.919 ± 0.070 | 1.135 | 0.929 | 1.236 | 0.027 |
| Phospholipids | ||||||
| Phosphatidylcholine #2b | 1.059 ± 0.046 | 0.930 ± 0.027 | 1.035 | 0.915 | 1.113 | 0.035 |
| Catecholamines | ||||||
| 3-Methoxytyrosine | 37.400 ± 0.020 | 40.567 ± 0.029 | 37.500 | 40.500 | 0.924 | 0.038 |
| Vitamins, co-factors, and related | ||||||
| Coenzyme Q10 | 1.148 ± 0.053 | 0.700 ± 0.164 | 1.132 | 0.639 | 1.618 | 0.014 |
| Miscellaneous | ||||||
| Taurine | 1.210 ± 0.163 | 0.651 ± 0.088 | 1.135 | 0.624 | 1.745 | 0.011 |
| Benzoic acid | 0.936 ± 0.021 | 1.031 ± 0.027 | 0.946 | 1.011 | 0.918 | 0.014 |
| 2-Hydroxybutyrate | 1.044 ± 0.088 | 0.769 ± 0.036 | 1.066 | 0.752 | 1.386 | 0.015 |
| Creatinine | 0.874 ± 0.042 | 1.035 ± 0.052 | 0.862 | 0.988 | 0.832 | 0.024 |
aMeasurement may include a possible contribution from 3-indoxylsulfuric acid
bStructure annotation is based on strong analytical evidence (combinations of chromatography, mass spectrometry, chemical reactions, deuterium-labeling, database and literature search, as well as comparisons to similar/homologue/isomeric reference compounds)
Summary of area of impact, direction of change (increased ↑ or decreased ↓), and probable direction of impact (positive + or negative −) for significantly altered metabolites
| Area of impact | Metabolite | Direction of change | Direction of impact |
|---|---|---|---|
| GI microbial composition | Benzoic acid | ↓ | Neutral |
| 2-Hydroxybutyrate | ↑ | Neutral | |
| 3-Hydroxyindole | ↓ | + | |
| Myo and scyllo-inositol | ↑ | + | |
| Healthier GI tract | Threonine | ↑ | + |
| Citrulline | ↑ | + | |
| Taurine | ↑ | + | |
| α-Ketoglutarate | ↑ | + | |
| Increased growth | Methionine | ↑ | + |
| Threonine | ↑ | + | |
| Urea | ↓ | + | |
| Creatinine | ↓ | +/− | |
| Hydroxyproline | ↑ | + | |
| α-Ketoglutarate | ↑ | + | |
| Immune system | Methionine | ↑ | + |
| Threonine | ↑ | + | |
| Taurine | ↑ | + | |
| Coenzyme Q10 | ↑ | + | |
| Arachidonic acid | ↑ | +/− |